sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Dec-2015 02:00
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1117.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 15-Oct-2015
AIDS and Behavior
Researchers propose novel solution to HIV prevention
Enemas are commonly used by men who have sex with men (MSM) and transwomen (TW) before sexual intercourse. But these groups are vulnerable to HIV and other sexually transmitted infections (STIs) because enemas can seriously damage the thin tissue lining the rectum. A research group led by a UC Riverside assistant professor that worked recently with Peruvian MSM and TW proposes a rectal microbicide formulated as an enema to prevent HIV and possibly other STIs.
Merck & Co., Inc., National Institutes of Health

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 15-Oct-2015
New England Journal of Medicine
Sexual transmission of Ebola virus in Liberia confirmed using genomic analysis
A suspected case of sexual transmission of Ebola virus disease in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by US Army scientists in collaboration with the Liberian Institute for Biomedical Research. The work, described in today's edition of the New England Journal of Medicine, provides molecular evidence of Ebola virus transmission between a disease survivor and his female partner. It also demonstrates the value of real-time genomic surveillance during an outbreak.
Defense Threat Reduction Agency, Global Biosurveillance Technology Initiative, Global Emerging Infections Surveillance, Illumina, NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 15-Oct-2015
IDRI, Sanofi Pasteur team with philanthropy to develop new model for vaccine development
In an effort to accelerate timelines and decrease development costs of life-saving vaccines, the Infectious Disease Research Institute and Sanofi Pasteur today announce the establishment of the Global Health Vaccine Center of Innovation, to be headquartered at IDRI in Seattle. This project is funded in part by a grant from the Bill & Melinda Gates Foundation.
Sanofi Pasteur, Bill and Melinda Gates Foundation

Contact: Lee Schoentrup
Infectious Disease Research Institute

Public Release: 15-Oct-2015
PLOS Neglected Tropical Diseases
Infection with 2 species of schistosome does not affect treatment efficacy
The parasitic disease schistosomiasis is caused by a trematode flatworm, different species of which can affect either the intestine or the urinary tract. Mixed species (co-) infections are common, and research is needed to understand exactly how infection by both urinary and intestinal parasites affects the course of infection and response to treatment.
European Union, Bill and Melinda Gates Foundation

Contact: Sarah C. L. Knowles

Public Release: 13-Oct-2015
Cancer Cell
Armed malaria protein found to kill cancer cells
In models of non-Hodgkin's lymphoma, castration-resistant prostate cancer, and metastatic breast cancer, the Kairos-VAR2 therapeutic demonstrated the ability to prevent tumor growth, regress established tumors, and cure metastatic disease. The studies were published today in the journal Cancer Cell.

Contact: John Babcook
The Centre for Drug Research and Development

Public Release: 13-Oct-2015
Scientific Reports
Antiviral favipiravir successfully treats Lassa virus in guinea pigs
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from NIH scientists and colleagues.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 13-Oct-2015
In dryland African regions, limiting wildlife water access can reduce water quality
Water-dependent wildlife populations in sensitive African dryland regions need continued access to limited surface water resources -- even as human development increases in these areas -- because restricting access and concentrating wildlife populations along riparian regions can impact water quality and, potentially, human health.

Contact: Lynn Davis
Virginia Tech

Public Release: 13-Oct-2015
£3.5 million grant to improve prevention of tuberculosis in South African schoolchildren
The Medical Research Council has awarded a grant of £3.5 million to researchers from Queen Mary University of London and University of Cape Town to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis in South African primary school children.
Medical Research Council

Contact: Rupert Marquand
Queen Mary, University of London

Public Release: 13-Oct-2015
Nature Medicine
New study has important implications for the design of a protective HIV vaccine
A Ph.D. student from Wits University published a study describing how the changing viral swarm in an HIV infected person can drive the generation of antibodies able to neutralize HIV strains from across the world. The study has important implications for the design of a protective HIV vaccine.

Contact: Kemantha Govender
University of the Witwatersrand

Public Release: 13-Oct-2015
Nature Communications
Tulane researchers working on new tuberculosis vaccine
Researchers at the Tulane National Primate Research Center are leading efforts to find a new vaccine for tuberculosis, one of the world's deadliest diseases. A team of researchers led by the TNPRC used a modified strain of TB to show that monkeys could generate better protective immunity than when vaccinated with BCG, a common TB vaccine.
National Institutes of Health

Contact: Carolyn Scofield
Tulane University

Public Release: 13-Oct-2015
Cancer Cell
Destructive disease shows potential as a cancer treatment
Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

Contact: Faydra Aldridge
604-875-4111 x66687
University of British Columbia

Public Release: 12-Oct-2015
Nature Communications
Genes linked with malaria's virulence shared by apes, humans
The malaria parasite molecules associated with severe disease and death have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health. This new information could aid in basic understanding of the causes of malaria and provide targets for drugs and vaccines.
National Institutes of Health, Wellcome Trust

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 12-Oct-2015
American Journal of Tropical Medicine and Hygiene
Comprehensive genomic study provides evidence that dengue has become endemic and diverse in China
The first-ever comprehensive genomic analysis of the virus that causes dengue fever suggests that it may survive year-round in southern China. The study, published in the American Journal of Tropical Medicine and Hygiene, provides evidence that China may be at increased risk for more frequent and severe dengue fever outbreaks similar to the 2014 outbreak in Guangdong Province that sickened more than 40,000 people.

Contact: Bridget DeSimone
Burness Communications

Public Release: 9-Oct-2015
IDWeek 2015
Antiviral compound provides full protection from Ebola virus in nonhuman primates
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.
Defense Threat Reduction Agency, Medical Countermeasure Systems Joint Project Management Office, US Department of Defense

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 8-Oct-2015
US and Canada partner to invest $21 million for research hubs in developing countries
The National Institutes of Health and other US and Canadian partners are investing $20.9 million dollars over five years to establish seven regional research and training centers in low- and middle-income countries. The Global Environmental and Occupational Health Hubs will consist of multidisciplinary groups of researchers and partner organizations collaborating on common research and training topics that address environmental and/or occupational health issues.
National Institutes of Health, National Institute for Occupational Safety and Health, Canadian International Development Research Centre, Global Alliance for Clean Cookstoves

Contact: Ann Puderbaugh
NIH/Fogarty International Center

Public Release: 8-Oct-2015
Water, Air and Soil Journal
Ben-Gurion U. and MIT researchers develop rapid method for water, soil pathogen screening
The study, published online in the Water, Air & Soil Pollution journal (Springer) defines an accurate, inexpensive, high-throughput, and rapid alternative for screening of pathogens from various environmental samples. 'This is the first study to comprehensively assess pathogen concentrations in such a broad variety of environmental sample types while achieving multiple pathogen detection with complete parallel testing by standard (or traditional) methods,' Orlofsky explains.
U.S.-Israel Binational Agricultural Research and Development Fund, Israel Water Authority, BGU's Kreitman School for Graduate Studies, and Maccabi Fund

Contact: andrew Lavin
American Associates, Ben-Gurion University of the Negev

Public Release: 8-Oct-2015
Clinical Infectious Diseases
Salmonella unmasked as major killer of young children in Africa
Invasive Salmonella infections in sub-Saharan Africa are a major cause of child illness and deaths, a new body of research into this usually overlooked infectious disease has revealed. In the West, Salmonella is commonly thought of as a bacterium responsible for relatively benign cases of food poisoning. However, a supplement to the leading infectious diseases journal Clinical Infectious Diseases published today now exposes the unacceptable toll of sickness and death caused by invasive Salmonella infections in sub-Saharan Africa.
Bill & Melinda Gates Foundation, Wellcome Trust

Contact: John Crump
University of Otago

Public Release: 6-Oct-2015
Proceedings of the National Academy of Sciences
Study: Link between dengue epidemics and high temperatures during strong El Niño season
Epidemics of dengue are linked to high temperatures brought by the El Niño weather phenomenon, a University of Florida scientist working with an international team of researchers has found.
Bill & Melinda Gates Foundation, NIH/National Institute of General Medical Sciences

Contact: Derek Cummings
University of Florida

Public Release: 6-Oct-2015
Tufts biophysicist receives NIH New Innovator Award for Ebola research
James Munro of Tufts University School of Medicine is a recipient of the 2015 National Institutes of Health Director's New Innovator Award. Munro is using imaging of glycoproteins to investigate how Ebola and related viruses enter host cells. Understanding this process is expected to help develop vaccines for Ebola and related viruses.
National Institutes of Health

Contact: Siobhan Gallagher
Tufts University, Health Sciences Campus

Public Release: 5-Oct-2015
Journal of Virology
Dengue protein modulates human enzyme: Fuel for replication
A new study published in the Journal of Virology reveals that NS1, a nonstructural protein composing the replication machinery of the dengue virus, binds to a well-known human enzyme as a way to increase energy production to be used for viral replication.

Contact: Ronaldo Mohana Borges
Publicase Comunicação Científica

Public Release: 5-Oct-2015
Journal of Advanced Nursing
How health professionals help and hinder eradication of female genital mutilation
A new article highlights how health professionals -- including nurses and midwives -- both help and hinder eradication and management of female genital mutilation.

Contact: Dawn Peters

Public Release: 5-Oct-2015
European Journal of Neurology
Africa faces rising rates of traumatic brain injury
New research reveals that the projected estimates of traumatic brain injury in Africa are high, with a burden of anywhere between approximately 6 to 14 million new cases in 2050. Most cases will result from motor vehicle accidents.

Contact: Dawn Peters

Public Release: 5-Oct-2015
EU funding to support chronic lung disease research
Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry are part of an international consortium which has received funding of almost €3 million from the EU Horizon 2020 programme, to investigate methods to prevent, diagnose and treat non-communicable lung disease (such as asthma and chronic pulmonary obstructive disorder - COPD) in low and middle income countries.
Horizon 2020

Contact: Andrew Gould
University of Plymouth

Public Release: 5-Oct-2015
Proceedings of the National Academy of Sciences
Dengue epidemics linked to high temperatures during strong El Nino season
An international research team led by the University of Pittsburgh Graduate School of Public Health has shown that epidemics of dengue, which is caused by a mosquito-borne virus, across southeast Asia appear to be linked to the abnormally high temperatures brought by the El Niño weather phenomenon. Now, as the most intense El Niño in nearly two decades is emerging in the Pacific, the finding may be a harbinger of a spike in cases.
NIH/National Institute of General Medical Sciences

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 2-Oct-2015
Pneumothorax treatment gets less painful
Scientists working in Tianjin Chest Hospital, China, have developed a less painful treatment strategy for Pneumothorax treatment. By analyzing the partial pressure of oxygen and carbon dioxide in thoracic cavity gas during Pneumothorax Treatment, physicians can understand the real conditions of the pneumothorax and then update to a less painful treatment method.

Contact: Philly Lim
World Scientific

Showing releases 76-100 out of 1117.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>